Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Hruby

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 3, 2020
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK TrialPaul Keall, Doan Trang Nguyen, Ricky O'Brien, et al.
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
European Urology Focus|November 28, 2024
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following ProstatectomyConstantinos Zamboglou, Paulina Staus, Martin Wolkewitz, et al.
Medical Physics|November 23, 2024
The TROG 15.01 stereotactic prostate adaptive radiotherapy utilizing kilovoltage intrafraction monitoring (SPARK) clinical trial databaseChandrima Sengupta, Doan Trang Nguyen, Yifan Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2024
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2026
PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomySophia Scharl, Reinhard Thamm, Constantinos Zamboglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 28, 2024
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysisChristian Trapp, Daniel M Aebersold, Claus Belka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III TrialAngela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|April 3, 2020
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK TrialPaul Keall, Doan Trang Nguyen, Ricky O'Brien, et al.
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
European Urology Focus|November 28, 2024
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following ProstatectomyConstantinos Zamboglou, Paulina Staus, Martin Wolkewitz, et al.
Medical Physics|November 23, 2024
The TROG 15.01 stereotactic prostate adaptive radiotherapy utilizing kilovoltage intrafraction monitoring (SPARK) clinical trial databaseChandrima Sengupta, Doan Trang Nguyen, Yifan Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2024
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2026
PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomySophia Scharl, Reinhard Thamm, Constantinos Zamboglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 28, 2024
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysisChristian Trapp, Daniel M Aebersold, Claus Belka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III TrialAngela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
Pageof 13